Form 4: CME Group Director Dennis Suskind Acquires Shares Through Stock Plan

CME Group Inc. Director Dennis Suskind acquired 532 shares of Common Stock Class A at $273.03 per share on June 25, 2025, as part of the company's Director Stock Plan.

Summary

• Dennis Suskind, a Director of CME Group Inc. (CME), reported an acquisition of company shares.
• The transaction involved the acquisition of 532 shares of Common Stock Class A.
• The shares were acquired at a price of $273.03 per share.
• The acquisition was made on June 25, 2025.
• Following this transaction, Dennis Suskind beneficially owns a total of 3,447 shares of Common Stock Class A.
• The shares were granted pursuant to the CME Group Director Stock Plan, as amended and restated.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, particularly as part of a stock plan, is generally viewed positively as it aligns management's interests with shareholders, though it's a routine compensation event rather than a discretionary open-market purchase.

Positives

• Director Dennis Suskind increased his beneficial ownership in CME Group Inc., which can signal confidence in the company's future prospects.
• The acquisition was part of a pre-existing Director Stock Plan, aligning the director's incentives with shareholder interests through equity compensation.

Future Outlook

The document, an SEC Form 4, reports an insider transaction and does not provide any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details a routine insider transaction for CME Group Inc., a leading financial derivatives exchange. Such transactions are common for directors and executives as part of their compensation plans and do not typically reflect broader industry trends, though they are closely watched for insights into insider sentiment.

Corporate Governance

Related Party Transactions

• Acquisition of 532 shares of Common Stock Class A by Director Dennis Suskind from CME Group Inc. at $273.03 per share, granted under the CME Group Director Stock Plan.

Stakeholder Impact

• Shareholders: The increase in director ownership may be viewed positively as it enhances alignment between management and shareholder interests.

Key Dates

Keywords

CME Group, CME, Dennis Suskind, Form 4, Insider Trading, Stock Acquisition, Director Stock Plan, Common Stock